Cyclopharm Ltd has released a press release.
Cyclopharm to Proceed Independently with FDA Trials
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cyclopharm
- Cyclopharm Files Claim Against ANSTO
- Trading Update
- Renounceable Rights Issue and Sale of Unmarketable Parcels
- Renewal of Debt Facility with National Australia Bank
- Regulatory Approval in China
Later from Cyclopharm
- Trading Update & Record Technegas Order Received from China
- CYC Signs Agreement with the Canadian Association of Nuc Med
- Appendix 4D and Half Year Accounts
- Cyclopharm Business Update on Significant Milestones
- CYC Achieves USFDA Agreement For Technegas Trial Design
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm